Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

OBJECTIVES: Pulmonary fibrosis is a leading cause of death in systemic sclerosis (SSc). This report examines the differences at baseline and over 12 months between patients with limited versus diffuse cutaneous SSc who participated in the Scleroderma Lung Study. METHODS: SSc patients (64 limited; 94...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Clements, P J, Roth, M D, Elashoff, R, Tashkin, D P, Goldin, J, Silver, R M, Sterz, M, Seibold, J R, Schraufnagel, D, Simms, R W, Bolster, M, Wise, R A, Steen, V, Mayes, M D, Connelly, K, Metersky, M, Furst, D E
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2007
Assuntos:
Extended Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095310/
https://ncbi.nlm.nih.gov/pubmed/17485423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.069518
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares